Multivariate logistic regression analysis of serum PRL levels and NAFLD risk
| Men | Women | |||||
| β | OR (95% CI) | P value | β | OR (95% CI) | P value | |
| Age | −0.045 | 0.956 (0.924 to 0.989) | 0.010 | −0.044 | 0.957 (0.912 to 1.004) | 0.070 |
| BMI | 0.255 | 1.291 (1.122 to 1.484) | 0.000 | 0.090 | 1.094 (0.97 to 1.224) | 0.120 |
| Menopause | 0.213 | 1.237 (0.281 to 5.441) | 0.778 | |||
| TG | 0.176 | 1.193 (0.959 to 1.483) | 0.113 | 0.981 | 2.666 (1.404 to 5.064) | 0.003 |
| LDL | 0.493 | 1.637 (1.046 to 2.561) | 0.031 | −0.121 | 0.886 (0.596 to 1.318) | 0.550 |
| HOMA-IR (CP) | 0.360 | 1.134 (1.062 to 1.936) | 0.019 | 0.215 | 1.240 (0.859 to 1.788) | 0.250 |
| HbA1c | 0.057 | 1.059 (0.872 to 1.287) | 0.564 | 0.047 | 1.048 (0.840 to 1.308) | 0.676 |
| PRL | −0.115 | 0.891 (0.803 to 0.989) | 0.031 | −0.135 | 0.874 (0.797 to 0.957) | 0.004 |
The risk factors for NAFLD were assessed using multiple logistic regression analysis in men and women. The ORs with corresponding 95% CIs were adjusted for age, BMI, menopause, TG, LDL and HOMA-IR (CP), HbA1c and PRL levels as variables.
BMI, body mass index; HbA1c, glycosylated haemoglobin; HOMA-IR (CP), homoeostasis model assessment for insulin resistance (C-peptide); LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease; PRL, prolactin; TG, triglyceride.